The NY OCM’s latest staff changes include OCM Chief Equity Officer Update: OCM’s Chief Equity Officer, Damian Fagon, has announced his resignation from the agency, effective November 27, 2024. This announcement comes after conclusion of the NYS Inspector General investigation, which resulted in a determination that the allegations at issue for that investigation were unsubstantiated. Fagon […]

The Cannabis Control Board voted on Sept. 25 to temporarily close the window for new retail and tier 2 cultivation applications. The Board is committed to adapting to changing market conditions. At the September meeting, all three members spoke of their concern for oversaturation in the regulated cannabis market. “We know that these have dramatic […]

In March of 2023, Oregon’s cannabis industry faced threatening regulations that would quickly force many producers to the brink of total losses. These regulations required cannabis products test at 0% for a common mold named Aspergillus, or risk violations. Join our webinar for a highly insightful breakdown from members of the team that filed the […]

The German Cannabis Business Association reports At its 114th cabinet meeting, the federal government decided to implement the draft of a Cannabis Liberalization Act (NLG). The German Cannabis Business Association (BvCW) welcomes the key elements of the reform: the abolition of the so-called “intoxication clause” the simplification of the cultivation of industrial hemp the facilitation of indoor cultivation of […]

Industrial hemp “Zukunft Bau”: Research funding for industrial hemp as a sustainable alternative in the construction industry Several funded research projects are currently investigating the use of natural fibers such as hemp and flax as well as bio-based materials as sustainable alternatives in the construction industry: TU Dortmund University is researching the long-term behavior and shear […]

  09/23/2024 | The commercial law firm Oppenhoff is strengthening its healthcare and M&A practice with Franziska Katterbach as a new partner at its Frankfurt office. Katterbach will join Oppenhoff on October 1, 2024 from Khiron Life Sciences, a medical cannabis company, reports Legal Tribune Online. She was previously Managing Director for Khiron’s European business and also worked for Canopy Growth, also […]